Tovecimig (a DLL4 x VEGF-A bispecific antibody) in combination with paclitaxel demonstrated a highly statistically significant improvement versus ...

Researchers at Carnegie Mellon University's School of Computer Science (SCS) revealed how small design changes in online tutoring platforms can help students push through their mistakes and keep ...

Morehead State University and the Craft Academy for Excellence in Science & Mathematics continue to produce alumni who go on ...

Older adults with type 2 diabetes face a difficult trade-off: they are among the most vulnerable to medication-related harms ...

An FDA initiative to implement real-world clinical trials could dramatically accelerate the pace at which new treatments ...

Oruka Therapeutics’ long-acting plaque psoriasis candidate cleared the skin of 63.5% of patients in a phase 2a trial, leading ...

When Susan Burton lost her 5-year-old son after he was struck by a police vehicle in Los Angeles, her grief drove her into ...

FDA has previously agreed on the design of this 300-patient randomized, placebo-controlled confirmatory Phase 3 trial, and the 12-month primary endpoint of pain reduction as an approvable indication.

On April 27, 2026, Veradermics, Inc. disclosed that its experimental oral hair-loss drug VDPHL01 hit the primary efficacy ...

Automated text message reminders with embedded behavioral nudges are linked to higher colorectal cancer screening completion ...

Colorectal cancer (CRC) is the second most common cause of cancer death in the United States and disproportionately impacts ...